연구성과로 돌아가기
JCR 2023 저널 목록 (1199 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Genitourinary Cancer | CIG MEDIA GROUP, LP | 1558-7673 | 1938-0682 | SCIE | ONCOLOGY | 3,330 | 2.3 | Q3 | 62.6 | 37.4 | 202/322 | 2.3 | Q3 | 2.2 | 0.9 | 0.83 | 108/322 | Q2 | 66.61 | 0.006 | 1.269 | 0.791 | Q3 | 155 | 87.1% | 4.8 | 5.5 | 135 | 13.3% | 2025-03-24 17:33:51 | 바로가기 |
| Contemporary Clinical Trials | ELSEVIER SCIENCE INC | 1551-7144 | 1559-2030 | SCIE | PHARMACOLOGY & PHARMACY | 5,359 | 2.0 | Q3 | 62.6 | 37.4 | 222/354 | 2.1 | Q3 | 2.0 | 0.3 | 0.58 | 206/354 | Q3 | 41.95 | 0.009 | 1.954 | 0.917 | Q2 | 242 | 100.0% | 6.7 | 8.9 | 242 | 19.4% | 2025-03-24 17:36:22 | 바로가기 |
| CURRENT CANCER DRUG TARGETS | BENTHAM SCIENCE PUBL LTD | 1568-0096 | 1873-5576 | SCIE | ONCOLOGY | 3,163 | 2.3 | Q3 | 62.6 | 37.4 | 202/322 | 3.1 | Q2 | 2.3 | 1.0 | 0.45 | 226/322 | Q3 | 29.97 | 0.002 | 0.391 | 0.582 | Q3 | 70 | 55.7% | 9.2 | 7.3 | 39 | 1.9% | 2025-03-24 17:33:52 | 바로가기 |
| DIGESTIVE DISEASES | KARGER | 0257-2753 | 1421-9875 | SCIE | GASTROENTEROLOGY & HEPATOLOGY | 2,984 | 2.0 | Q3 | 62.6 | 37.4 | 90/143 | 2.2 | Q3 | 2.0 | 0.8 | 0.48 | 85/143 | Q3 | 40.91 | 0.002 | 0.429 | 0.591 | Q3 | 65 | 78.5% | 8.1 | 8.0 | 51 | 25.3% | 2025-03-24 17:15:00 | 바로가기 |
| Drug Target Insights | ABOUTSCIENCE SRL | 1177-3928 | 1177-3928 | ESCI | PHARMACOLOGY & PHARMACY | 228 | 2.0 | Q3 | 62.6 | 37.4 | 222/354 | 2.4 | Q3 | 1.9 | 0.6 | 0.39 | 273/354 | Q4 | 23.02 | 0.000 | 0.023 | 0.468 | Q3 | 13 | 69.2% | 10.1 | 6.9 | 9 | 93.1% | 2025-03-24 17:36:47 | 바로가기 |
| Endocrine Metabolic & Immune Disorders-Drug Targets | BENTHAM SCIENCE PUBL LTD | 1871-5303 | 2212-3873 | SCIE | PHARMACOLOGY & PHARMACY | 2,408 | 2.0 | Q3 | 62.6 | 37.4 | 222/354 | 2.2 | Q3 | 1.9 | 0.9 | 0.42 | 265/354 | Q3 | 25.28 | 0.002 | 0.503 | 0.372 | Q3 | 176 | 65.9% | 3.8 | 7.6 | 116 | 1.6% | 2025-03-24 17:36:31 | 바로가기 |
| EUROPEAN JOURNAL OF OPHTHALMOLOGY | SAGE PUBLICATIONS LTD | 1120-6721 | 1724-6016 | SCIE | OPHTHALMOLOGY | 5,254 | 1.5 | Q3 | 62.6 | 37.4 | 60/95 | 1.6 | Q3 | 1.4 | 0.2 | 0.60 | 59/95 | Q3 | 38.42 | 0.007 | 1.633 | 0.482 | Q3 | 302 | 86.8% | 3.9 | 8.4 | 262 | 5.9% | 2025-03-24 17:34:25 | 바로가기 |
| EXPERIMENTAL TECHNIQUES | SPRINGER | 0732-8818 | 1747-1567 | SCIE | ENGINEERING, MECHANICAL | 1,317 | 1.5 | Q3 | 62.6 | 37.4 | 115/183 | 1.5 | Q3 | 1.4 | 0.3 | 0.46 | 105/183 | Q3 | 42.90 | 0.001 | 0.190 | 0.262 | Q3 | 62 | 98.4% | 6.7 | 7.6 | 61 | 7.7% | 2025-03-24 17:11:54 | 바로가기 |
| Frontiers in Rehabilitation Sciences | FRONTIERS MEDIA SA | N/A | 2673-6861 | ESCI | REHABILITATION | 556 | 1.3 | Q3 | 62.6 | 37.4 | 107/170 | 1.3 | Q4 | 1.3 | 0.4 | 0.59 | 120/170 | Q3 | 29.71 | 0.001 | 0.221 | 0.334 | Q4 | 166 | 86.8% | 1.7 | 7.9 | 144 | 99.8% | 2025-03-24 18:08:32 | 바로가기 |
| Gastroenterology Research and Practice | HINDAWI LTD | 1687-6121 | 1687-630X | SCIE | GASTROENTEROLOGY & HEPATOLOGY | 3,893 | 2.0 | Q3 | 62.6 | 37.4 | 90/143 | 2.0 | Q3 | 2.0 | 0.4 | 0.39 | 99/143 | Q3 | 31.12 | 0.003 | 0.723 | 0.512 | Q3 | 33 | 84.8% | 7.0 | 7.1 | 28 | 100.0% | 2025-03-24 17:14:58 | 바로가기 |
| IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY | IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC | 0018-9375 | 1558-187X | SCIE | TELECOMMUNICATIONS | 6,264 | 2.0 | Q3 | 62.6 | 37.4 | 75/119 | 2.0 | Q3 | 1.5 | 0.2 | 0.49 | 73/119 | Q3 | 39.08 | 0.004 | 0.984 | 0.413 | Q3 | 221 | 100.0% | 7.5 | 8.6 | 221 | 6.6% | 2025-03-24 18:13:30 | 바로가기 |
| Indian Journal of Gastroenterology | SPRINGER INDIA | 0254-8860 | 0975-0711 | ESCI | GASTROENTEROLOGY & HEPATOLOGY | 1,706 | 2.0 | Q3 | 62.6 | 37.4 | 90/143 | 2.1 | Q3 | 1.7 | 1.3 | 0.49 | 81/143 | Q3 | 43.71 | 0.001 | 0.296 | 0.495 | Q3 | 111 | 81.1% | 6.2 | 7.3 | 90 | 5.8% | 2025-03-24 17:15:02 | 바로가기 |
| INDUSTRIAL LUBRICATION AND TRIBOLOGY | EMERALD GROUP PUBLISHING LTD | 0036-8792 | 1758-5775 | SCIE | ENGINEERING, MECHANICAL | 2,039 | 1.5 | Q3 | 62.6 | 37.4 | 115/183 | 1.4 | Q3 | 1.3 | 0.3 | 0.41 | 115/183 | Q3 | 37.43 | 0.001 | 0.305 | 0.201 | Q4 | 124 | 97.6% | 5.1 | 6.2 | 121 | 1.0% | 2025-03-24 17:11:52 | 바로가기 |
| INTERNATIONAL JOURNAL OF AUTOMOTIVE TECHNOLOGY | KOREAN SOC AUTOMOTIVE ENGINEERS-KSAE | 1229-9138 | 1976-3832 | SCIE | ENGINEERING, MECHANICAL | 2,291 | 1.5 | Q3 | 62.6 | 37.4 | 115/183 | 1.6 | Q3 | 1.4 | 0.4 | 0.34 | 131/183 | Q3 | 28.69 | 0.002 | 0.365 | 0.292 | Q3 | 136 | 99.3% | 5.9 | 7.0 | 135 | 0.0% | 2025-03-24 17:11:51 | 바로가기 |
| INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | SAGE PUBLICATIONS LTD | 0393-6155 | 1724-6008 | SCIE | ONCOLOGY | 1,356 | 2.3 | Q3 | 62.6 | 37.4 | 202/322 | 2.3 | Q3 | 2.3 | 0.5 | 0.46 | 221/322 | Q3 | 31.52 | 0.001 | 0.210 | 0.458 | Q4 | 31 | 80.6% | 6.8 | 6.4 | 25 | 95.2% | 2025-03-24 17:33:59 | 바로가기 |
페이지 이동: